down arrow

HUTCHMED (China) Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG4672N1198
HKD
23.28
-194.47 (-89.31%)

Feb 16

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sino Biopharmaceutical Ltd.
China Medical System Holdings Ltd.
WuXi AppTec Co., Ltd.
Sinopharm Group Co., Ltd.
China Resources Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
Hansoh Pharmaceutical Group Co., Ltd.
Innovent Biologics, Inc.
Akeso, Inc.
HUTCHMED (China) Ltd.
BeiGene Ltd.

Why is HUTCHMED (China) Ltd. ?

1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 3.79%
  • Poor long term growth as Operating profit has grown by an annual rate 12.33% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -888.56
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 9.30%, its profits have risen by 1203.9%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is HUTCHMED (China) Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
HUTCHMED (China) Ltd.
-100.0%
-1.72
52.03%
Hang Seng Hong Kong
18.06%
0.71
25.51%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
22.83%
EBIT Growth (5y)
12.33%
EBIT to Interest (avg)
-888.56
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.99
Sales to Capital Employed (avg)
0.69
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
3.79%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
2.14
EV to EBIT
-69.61
EV to EBITDA
-183.11
EV to Capital Employed
-32.38
EV to Sales
2.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
37.76%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
ROCE(HY)

Highest at 47.17%

CASH AND EQV(HY)

Highest at HKD 10,711.48 MM

PRE-TAX PROFIT(Q)

Highest at HKD 3,861.99 MM

NET PROFIT(Q)

Highest at HKD 3,545.31 MM

EPS(Q)

Highest at HKD 4.06

-3What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 35.49% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.4%

NET SALES(Q)

Lowest at HKD 2,163.85 MM

Here's what is working for HUTCHMED (China) Ltd.

Pre-Tax Profit
At HKD 3,861.99 MM has Grown at 10,485.11%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Net Profit
At HKD 3,545.31 MM has Grown at 1,657.36%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (HKD MM)

Pre-Tax Profit
Highest at HKD 3,861.99 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit
Highest at HKD 3,545.31 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS
Highest at HKD 4.06
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Cash and Eqv
Highest at HKD 10,711.48 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for HUTCHMED (China) Ltd.

Net Sales
Lowest at HKD 2,163.85 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Debtors Turnover Ratio
Lowest at 3.4%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 35.49% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."